~5 spots leftby Apr 2025

Yoga for Non-Small Cell Lung Cancer

Recruiting in Palo Alto (17 mi)
Kathrin Milbury | MD Anderson Cancer Center
Overseen byKathrin Milbury, MA,PHD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: M.D. Anderson Cancer Center
Disqualifiers: Mind-body practice, CNS metastasis
No Placebo Group

Trial Summary

What is the purpose of this trial?This trial studies how well dyadic yoga intervention works in improving physical performance and quality of life in patients with stage I-IV non-small cell lung or esophageal cancer undergoing radiotherapy and their caregivers. Dyadic yoga intervention may help to improve physical function, fatigue, sleep difficulties, depressive symptoms, and overall quality of life for patients with non-small cell lung cancer and/or their caregivers.
Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Dyadic Yoga Intervention for Non-Small Cell Lung Cancer?

Research shows that yoga can improve physical and mental health in cancer patients, and it may help lung cancer patients maintain their quality of life by reducing declines in physical and psychosocial function.

12345
Is yoga safe for people with cancer, including those with lung cancer?

Yoga has been studied in cancer patients, including those undergoing radiotherapy, and is generally considered safe. It has shown benefits in reducing stress and improving mood without significant safety concerns.

12456
How is the Dyadic Yoga Intervention treatment different from other treatments for non-small cell lung cancer?

The Dyadic Yoga Intervention is unique because it involves partner-supported yoga, which aims to improve both psychosocial and physical function, enhancing quality of life for lung cancer patients. Unlike traditional treatments that focus on directly targeting cancer cells, this approach emphasizes mind-body practices to support overall well-being and is delivered in a supportive, couple-based format.

23457

Eligibility Criteria

This trial is for patients with stage I-IV non-small cell lung or esophageal cancer who are about to undergo at least 3 weeks of thoracic radiotherapy. They must be able to perform daily activities (ECOG <=2), speak English, and consent. Caregivers can join optionally if they're adults, speak English, and give consent. People practicing mind-body techniques in the past year or with brain metastases cannot join.

Inclusion Criteria

Having a family caregiver who assists the patient during the cancer treatment per patient self-report. Note, patients must identify a family caregiver; however, the participation of the family caregiver is optional. For caregivers to be eligible, they must be at least 18 years old; able to read, write and speak English; and able to provide informed consent. Family caregivers may consent to participate in the intervention and caregiver assessments or only the assessments based on their preference.
I can take care of myself but might not be able to do heavy physical work.
I have lung or esophageal cancer and will undergo 3 weeks of chest radiation.
+2 more

Exclusion Criteria

I have regularly practiced mind-body techniques like meditation or yoga before my diagnosis.
My cancer has spread to my brain or spinal cord.

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo dyadic yoga intervention or dyadic education program for up to 15 sessions, each lasting 60 minutes

15 sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment

6 months
Every 2 weeks for 3 months, then monthly for up to 6 months

Participant Groups

The study tests a dyadic yoga program's effectiveness on improving physical performance and life quality for both patients undergoing radiotherapy for certain cancers and their caregivers. It includes assessments through questionnaires and an educational component alongside the yoga intervention.
2Treatment groups
Experimental Treatment
Active Control
Group I: Group I (dyadic yoga)Experimental Treatment3 Interventions
Patients and caregivers undergo dyadic yoga intervention session involving physical exercises and relaxation techniques over 60 minutes each for up to 15 sessions.
Group II: Group II (dyadic education)Active Control3 Interventions
Patients and caregivers undergo dyadic education program session focusing on strategies of how to manage patient and caregiver symptoms over 60 minutes each for up to 15 sessions.

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
M D Anderson Cancer CenterHouston, TX
Loading ...

Who Is Running the Clinical Trial?

M.D. Anderson Cancer CenterLead Sponsor
National Cancer Institute (NCI)Collaborator

References

Utilizing Yoga in Oncologic Patients Treated with Radiotherapy: Review. [2022]Several trials on noncancer population indicate that yoga is associated with meaningful clinical effects. This study evaluated the physical and psychosocial outcomes of yoga in oncologic patients treated with radiotherapy.
Yoga Therapy in Cancer Care via Telehealth During the COVID-19 Pandemic. [2022]Yoga is an evidence-based mind-body practice known to improve physical and mental health in cancer patients. We report on the processes and patient-reported outcomes of one-on-one yoga therapy (YT) consultations delivered via telehealth.
Feasibility and potential benefits of partner-supported yoga on psychosocial and physical function among lung cancer patients. [2022]Patients with lung cancer experience significant declines in psychosocial and physical function during and after treatment that impact quality of life (QOL) and survival. Yoga is a potential strategy to mitigate functional decline among patients with lung cancer.
A pilot study of the feasibility and outcomes of yoga for lung cancer survivors. [2014]To determine the feasibility of a standardized yoga intervention for survivors of non-small cell lung cancer (NSCLC) and, effects on sleep, mood, salivary cortisol levels, and quality of life (QOL).
Vivekananda Yoga Program for Patients With Advanced Lung Cancer and Their Family Caregivers. [2022]The primary purpose of this study was to establish the feasibility of a couple-based Vivekananda Yoga (VKC) intervention in lung cancer patients and caregivers. Secondly, we examined preliminary efficacy regarding quality of life (QOL) outcomes.
Effects of an integrated yoga program in modulating psychological stress and radiation-induced genotoxic stress in breast cancer patients undergoing radiotherapy. [2022]Effects of an integrated yoga program in modulating perceived stress levels, anxiety, as well as depression levels and radiation-induced DNA damage were studied in 68 breast cancer patients undergoing radiotherapy. Two psychological questionnaires--Hospital Anxiety and Depression Scale (HADS) and Perceived Stress Scale (PSS)--and DNA damage assay were used in the study. There was a significant decrease in the HADS scores in the yoga intervention group, whereas the control group displayed an increase in these scores. Mean PSS was decreased in the yoga group, whereas the control group did not show any change pre- and postradiotherapy. Radiation-induced DNA damage was significantly elevated in both the yoga and control groups after radiotherapy, but the postradiotherapy DNA damage in the yoga group was slightly less when compared to the control group. An integrated approach of yoga intervention modulates the stress and DNA damage levels in breast cancer patients during radiotherapy.
Review of yoga therapy during cancer treatment. [2021]Reviews of yoga research that distinguish results of trials conducted during (versus after) cancer treatment are needed to guide future research and clinical practice. We therefore conducted a review of non-randomized studies and randomized controlled trials of yoga interventions for children and adults undergoing treatment for any cancer type.